Cargando…

Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study

INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) has a high mortality and requires effective treatment with anti-MRSA agents such as vancomycin (VCM). Management of the efficacy and safety of VCM has been implemented with the assignment of pharmacists in hospital wards and the establ...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Ryota, Muraki, Yuichi, Inose, Ryo, Kusama, Yoshiki, Ono, Akane, Koizumi, Ryuji, Ishikane, Masahiro, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462795/
https://www.ncbi.nlm.nih.gov/pubmed/36083990
http://dx.doi.org/10.1371/journal.pone.0274324
_version_ 1784787269581799424
author Goto, Ryota
Muraki, Yuichi
Inose, Ryo
Kusama, Yoshiki
Ono, Akane
Koizumi, Ryuji
Ishikane, Masahiro
Ohmagari, Norio
author_facet Goto, Ryota
Muraki, Yuichi
Inose, Ryo
Kusama, Yoshiki
Ono, Akane
Koizumi, Ryuji
Ishikane, Masahiro
Ohmagari, Norio
author_sort Goto, Ryota
collection PubMed
description INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) has a high mortality and requires effective treatment with anti-MRSA agents such as vancomycin (VCM). Management of the efficacy and safety of VCM has been implemented with the assignment of pharmacists in hospital wards and the establishment of teams related to infectious diseases. However, there are no reports evaluating the association between these factors and the efficacy and safety of VCM in large populations. METHODS: This study used the Japanese administrative claims database accumulated from 2010 to 2019. The population was divided into two groups, therapeutic drug monitoring (TDM) group and non-TDM group, and adjusted by propensity score matching. We performed multivariate logistic regression analysis to determine the influence of pharmacists and infection control teams or antimicrobial stewardship teams on acute kidney injury (AKI) and 30-day mortality. RESULTS: The total number of patients was 73 478 (TDM group, n = 55 269; non-TDM group, n = 18 209). After propensity score matching, 18 196 patients were matched in each group. Multivariate logistic regression analysis showed that pharmacological management for each patient contributed to the reduction of AKI (odds ratio [OR]: 0.812, 95% confidence interval [CI]: 0.723‒0.912) and 30-day mortality (OR: 0.538, 95% CI: 0.503‒0.575). However, the establishment of infectious disease associated team in facilities and the assignment of pharmacists in the hospital wards had no effect on AKI and 30-day mortality. In addition, TDM did not affect the reduction in AKI (OR: 1.061, 95% CI: 0.948‒1.187), but reduced 30-day mortality (OR: 0.873, 95% CI: 0.821‒0.929). CONCLUSION: Pharmacologic management for individual patients, rather than assignment systems at facilities, is effective to reduce AKI and 30-day mortality with VCM administration.
format Online
Article
Text
id pubmed-9462795
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-94627952022-09-10 Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study Goto, Ryota Muraki, Yuichi Inose, Ryo Kusama, Yoshiki Ono, Akane Koizumi, Ryuji Ishikane, Masahiro Ohmagari, Norio PLoS One Research Article INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) has a high mortality and requires effective treatment with anti-MRSA agents such as vancomycin (VCM). Management of the efficacy and safety of VCM has been implemented with the assignment of pharmacists in hospital wards and the establishment of teams related to infectious diseases. However, there are no reports evaluating the association between these factors and the efficacy and safety of VCM in large populations. METHODS: This study used the Japanese administrative claims database accumulated from 2010 to 2019. The population was divided into two groups, therapeutic drug monitoring (TDM) group and non-TDM group, and adjusted by propensity score matching. We performed multivariate logistic regression analysis to determine the influence of pharmacists and infection control teams or antimicrobial stewardship teams on acute kidney injury (AKI) and 30-day mortality. RESULTS: The total number of patients was 73 478 (TDM group, n = 55 269; non-TDM group, n = 18 209). After propensity score matching, 18 196 patients were matched in each group. Multivariate logistic regression analysis showed that pharmacological management for each patient contributed to the reduction of AKI (odds ratio [OR]: 0.812, 95% confidence interval [CI]: 0.723‒0.912) and 30-day mortality (OR: 0.538, 95% CI: 0.503‒0.575). However, the establishment of infectious disease associated team in facilities and the assignment of pharmacists in the hospital wards had no effect on AKI and 30-day mortality. In addition, TDM did not affect the reduction in AKI (OR: 1.061, 95% CI: 0.948‒1.187), but reduced 30-day mortality (OR: 0.873, 95% CI: 0.821‒0.929). CONCLUSION: Pharmacologic management for individual patients, rather than assignment systems at facilities, is effective to reduce AKI and 30-day mortality with VCM administration. Public Library of Science 2022-09-09 /pmc/articles/PMC9462795/ /pubmed/36083990 http://dx.doi.org/10.1371/journal.pone.0274324 Text en © 2022 Goto et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Goto, Ryota
Muraki, Yuichi
Inose, Ryo
Kusama, Yoshiki
Ono, Akane
Koizumi, Ryuji
Ishikane, Masahiro
Ohmagari, Norio
Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study
title Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study
title_full Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study
title_fullStr Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study
title_full_unstemmed Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study
title_short Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study
title_sort influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: a japanese administrative claims database study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462795/
https://www.ncbi.nlm.nih.gov/pubmed/36083990
http://dx.doi.org/10.1371/journal.pone.0274324
work_keys_str_mv AT gotoryota influenceofpharmacistsandinfectioncontrolteamsorantimicrobialstewardshipteamsonthesafetyandefficacyofvancomycinajapaneseadministrativeclaimsdatabasestudy
AT murakiyuichi influenceofpharmacistsandinfectioncontrolteamsorantimicrobialstewardshipteamsonthesafetyandefficacyofvancomycinajapaneseadministrativeclaimsdatabasestudy
AT inoseryo influenceofpharmacistsandinfectioncontrolteamsorantimicrobialstewardshipteamsonthesafetyandefficacyofvancomycinajapaneseadministrativeclaimsdatabasestudy
AT kusamayoshiki influenceofpharmacistsandinfectioncontrolteamsorantimicrobialstewardshipteamsonthesafetyandefficacyofvancomycinajapaneseadministrativeclaimsdatabasestudy
AT onoakane influenceofpharmacistsandinfectioncontrolteamsorantimicrobialstewardshipteamsonthesafetyandefficacyofvancomycinajapaneseadministrativeclaimsdatabasestudy
AT koizumiryuji influenceofpharmacistsandinfectioncontrolteamsorantimicrobialstewardshipteamsonthesafetyandefficacyofvancomycinajapaneseadministrativeclaimsdatabasestudy
AT ishikanemasahiro influenceofpharmacistsandinfectioncontrolteamsorantimicrobialstewardshipteamsonthesafetyandefficacyofvancomycinajapaneseadministrativeclaimsdatabasestudy
AT ohmagarinorio influenceofpharmacistsandinfectioncontrolteamsorantimicrobialstewardshipteamsonthesafetyandefficacyofvancomycinajapaneseadministrativeclaimsdatabasestudy